|
Real-time Estimate
Cboe BZX
02:31:49 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 22.18 USD | -3.73% |
|
+0.91% | +26.08% |
| 10-27 | Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading | MT |
| 10-26 | Zai Lab's Lung Cancer Drug Achieves Promising Response Rate in Phase 1b Trial; Shares up 4% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 2.59B | - | ||||
| 1,148B | |||||
| 652B | |||||
| 505B | |||||
| 384B | |||||
| 348B |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
